Northstar Advisory Group’s CME Group CME Stock Holding History

Northstar Advisory Group’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-814	Closed	-$220K	–	114
2025 Q3	$220K	Buy	+814	New	+$221K	0.09%	104

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northstar Advisory Group's CME Position: Q4 2025 in Review

Northstar Advisory Group sold out of CME Group (CME) in Q4 2025, closing a stake of 814 shares — an estimated $220K sold.

Northstar Advisory Group first reported a position in CME in Q3 2025 and held it in 1 quarter. The position peaked at $220K in Q3 2025. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.

Northstar Advisory Group reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
Northstar Advisory Group sold 814 CME Group shares in Q4 2025, an estimated $220K.
Northstar Advisory Group first reported a position in CME Group in Q3 2025 and held it in 1 quarter.
Northstar Advisory Group's CME Group position peaked at $220K in Q3 2025.
1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Northstar Advisory Group's 13F filing for Q4 2025, filed 15 Jan 2026.